Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AG2304T and AG2304R in Primary Hypercholesterolemia
NCT06717360Phase 3Completed
- Sponsor
- Ahn-Gook Pharmaceutical Co., Ltd.
- Start
- Sep 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of AG2304 in hypercholesterolemia, sponsored by Ahn-Gook Pharmaceutical Co., Ltd.. Started Sep 2024; status: completed.
02
Drugs
AG2304
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT06717360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06717360.